Browse by Person

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Item Type | Date | No Grouping
2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | 1997
Number of items: 26.

2012

Lalatsa, A., Lee, V.W.Y., Malkinson, J.P., Zloh, M., Schatzlein, A.G. and Uchegbu, I.F. (2012) A Prodrug Nanoparticle Approach for the Oral Delivery of a Hydrophilic Peptide, Leucine5-enkephalin, to the Brain. Molecular Pharmaceutics, 9 (6). pp. 1665-1680. 10.1021/mp300009u.

Brucoli, F., Natoli, A., Marimuthu, P., Borrello, M.T., Stapleton, P.D., Gibbons, S. and Schatzlein, A.G. (2012) Efficient synthesis and biological evaluation of proximicins A, B and C. Bioorganic and Medicinal Chemistry, 20 (6). pp. 2019-2024. 10.1016/j.bmc.2012.01.043.

Siew, A., Leake, H., Thiovolet, M., Gellert, P., Schatzlein, A.G. and Uchegbu, I.F. (2012) Enhanced Oral Absorption of Hydrophobic and Hydrophilic Drugs Using Quaternary Ammonium Palmitoyl Glycol Chitosan Nanoparticles. Molecular Pharmaceutics, 9 (1). pp. 14-28. 10.1021/mp200469a.

Moger, J., Garrett, N.L., Begley, D., Mihoreanu, L., Lalatsa, A., Lozano, M.V., Mazza, M., Schatzlein, A.G. and Uchegbu, I.F. (2012) Imaging cortical vasculature with stimulated Raman scattering and two-photon photothermal lensing microscopy. Journal of Raman Spectroscopy, 43 (5). pp. 668-674. 10.1002/jrs.3156.

Garrett, N.L., Lalatsa, A., Begley, D., Mihoreanu, L., Uchegbu, I.F., Schatzlein, A.G. and Moger, J. (2012) Label-free imaging of polymeric nanomedicines using coherent anti-stokes Raman scattering microscopy. Journal of Raman Spectroscopy, 43 (5). pp. 681-688. 10.1002/jrs.3170.

2011

Gunaratnam, M., Fuente, M.de la, Hampel, S.M., Todd, A.K., Reszka, A.P., Schatzlein, A.G. and Neidle, S. (2011) Targeting pancreatic cancer with a G-quadruplex ligand. Bioorganic & Medicinal Chemistry Letters, 19 (23). pp. 7151-7157. 1016/j.bmc.2011.09.055.

Guimaraes, A.M.R., Fuente, M.de la, Stapleton, P.D., Ji, X., Oliyide, A.O., Osbourn, A., Pandit, S., Bowles, D.J., Davis, B.G., Schatzlein, A.G. and Yang, M. (2011) Abstract: Glycosylation enhances selectivity of novobiocin and alters antibacterial mechanism. Abstract of Papers of the American Chemical Society, 241 (132-CARB).

Mazza, M., Gaisford, S., McCarthy, D., Schatzlein, A.G. and Uchegbu, I.F. (2011) Fast gelation of self-assembling peptide nanofibres triggered by electromagnetic radiation heating. In: Technical Proceedings of the 2011 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2011. NSTI-Nanotech, pp. 650-653. ISBN 978-143987142-3.

Patel, S.M., Fuente, M.de la, Ke, S., Guimarães, A.M.R., Oliyide, A.O., Ji, X., Stapleton, P.D., Osbourn, A., Pan, Y., Bowles, D.J., Davis, B.G., Schatzlein, A.G. and Yang, M. (2011) High throughput discovery of heteroaromatic-modifying enzymes allows enhancement of novobiocin selectivity. Chemical Communications, 47 (38). pp. 10569-10571. 10.1039/C1CC13552J .

2010

Ahmad, S., Johnston, B.F., Mackay, S.P., Schatzlein, A.G., Gellert, P., Sengupta, D. and Uchegbu, I.F. (2010) In silico modelling of drug-polymer interactions for pharmaceutical formulations. Journal of the Royal Society, Interface . 10.1098/rsif.2010.0190.focus.

Wong, P.E., Tetley, L., Dufès, C., Chooi, K.W., Bolton, K., Schatzlein, A.G. and Uchegbu, I.F. (2010) Polyamine aza-cyclic compounds demonstrate anti-proliferative activity in vitro but fail to control tumour growth in vivo. Journal of Pharmaceutical Sciences, 99 (11). pp. 4642-4657. 10.1002/jps.22165.

2009

Chisholm, E.J., Vassaux, G., Martin-Duque, P., Chevre, R., Lambert, O., Pitard, B., Merron, A., Weeks, M., Burnet, J., Peerlinck, I., Dai, M-S., Alusi, G., Mather, S.J., Bolton, K., Uchegbu, I.F., Schatzlein, A.G. and Baril, P. (2009) Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Research, 69 (6). pp. 2655-2662. 10.1158/0008-5472.CAN-08-2657.

Lee, V.W.Y., Uchegbu, I.F. and Schatzlein, A.G. (2009) Abstract: In-vivo biodistribution of amphiphilic polymer quaternary ammonium palmitoyl glycol chitosan in mice. Journal of Pharmacy and Pharmacology, 61 . A131-A132.

Schatzlein, A.G. (2009) Delivering on a promise? Synthetic vectors for the genetic therapy of cancer. Journal of Pharmacy and Pharmacology, 61 . A161-A162.

Seymour, L.W., Ferry, D.R., Kerr, D.J., Rea, D., Whitlock, M., Poyner, R., Boivin, C., Hesslewood, S., Twelves, C., Blackie, R., Schatzlein, A.G., Jodrell, D.I., Bissett, D., Calvert, H., Lind, M., Robbins, A., Burtles, S., Duncan, R. and Cassidy, J. (2009) Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. International Journal of Oncology, 34 (6). pp. 1629-1636. 10.3892/ijo_00000293 .

2008

Mazza, M., Uchegbu, I.F. and Schatzlein, A.G. (2008) Cancer and the Blood-Brain-Barrier: Trojan horses for courses? British Journal of Pharmacology, 155 (2). pp. 149-151. 10.1038/bjp.2008.274.

Holmes, W.M., Maclellan, S., Condon, B., Dufes, C., Evans, T.R., Uchegbu, I.F. and Schatzlein, A.G. (2008) High-resolution 3D isotropic MR imaging of mouse flank tumours obtained in vivo with solenoid RF micro-coil. Physics in Medicine and Biology, 53 . pp. 505-513. 10.1088/0031-9155/53/2/015.

2007

Bell, H.S., Dufes, C., O’Prey, J., Crighton, D., Bergamaschi, D., Lu, X., Schatzlein, A.G., Vousden, K.H. and Ryan, K.M. (2007) A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo. Journal of Clinical Investigation, 117 (4). pp. 1008-1018. 10.1172/JCI28920.

Guo, X., Evans, T.R.J., Somanath, S., Armesilla, A.L., Darling, J.L., Schatzlein, A.G., Cassidy, J. and Wang, W. (2007) In vitro evaluation of cancer-specific NF-κB-CEA enhancer–promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines. British Journal of Cancer, 97 (6). pp. 745-754. 10.1038/sj.bjc.6603930.

2006

Qu, X.Z., Khutoryanskiy, V.V., Stewart, A., Rahman, S.S., Papahadjopoulos-Sternberg, B., Dufes, C., McCarthy, D., Wilson, C.G., Lyons, R., Carter, K.C., Schatzlein, A.G. and Uchegbu, I.F. (2006) Carbohydrate-Based Micelle Clusters Which Enhance Hydrophobic Drug Bioavailability by Up to 1 Order of Magnitude. Biomacromolecules, 7 (12). pp. 3452-3459. 10.1021/bm0604000.

2005

Schatzlein, A.G., Zinselmeyer, B.H., Elouzi, A., Dufes, C., Chim, Y.A., Roberts, C.J., Davies, M.C., Munro, A., Gray, A. and Uchegbu, I.F. (2005) Preferential liver gene expression with polypropylenimine dendrimers. Journal of Controlled Release, 101 (1-3). pp. 247-258. 10.1016/j.jconrel.2004.08.024.

Dufes, C., Keith, W.N., Bilsland, A., Proutski, I., Uchegbu, I.F. and Schatzlein, A.G. (2005) Synthetic Anticancer Gene Medicine Exploits Intrinsic Antitumor Activity of Cationic Vector to Cure Established Tumors. Cancer Research, 65 (18). pp. 8079-8084. 10.1158/0008-5472.CAN-04-4402.

2004

Hollins, A.J., Benboubetra, M., Omidi, Y., Zinselmeyer, B.H., Schatzlein, A.G., Uchegbu, I.F. and Akhtar, S. (2004) Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor. Pharmaceutical Research, 21 (3). pp. 458-466. 10.1023/B:PHAM.0000019300.04836.51.

Kan, P.L., Papahadjopoulos-Sternberg, B., Wong, D., Waigh, R.D., Watson, D.G., Gray, A.I., McCarthy, D., McAllister, M., Schatzlein, A.G. and Uchegbu, I.F. (2004) Highly Hydrophilic Fused Aggregates (Microsponges) from a C12 Spermine Bolaamphiphile. Journal of Physical Chemistry B, 108 (24). pp. 8129-8135. 10.1021/jp0372237.

2002

Zinselmeyer, B.H., Mackay, S.P., Schatzlein, A.G. and Uchegbu, I.F. (2002) The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharmaceutical research, 19 (7). pp. 960-967.

1997

Uchegbu, I.F., Schatzlein, A.G., Vanlerberghe, G., Morgatini, N. and Florence, A.T. (1997) Polyhedral non-ionic surfactant vesicles. Journal of Pharmacy and Pharmacology, 49 (6). pp. 606-610. 10.1111/j.2042-7158.1997.tb06853.x.

This list was generated on Thu Dec 18 22:25:09 2014 GMT.